Voloridge Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.28M | Buy |
|
|||||
|
2025
Q3 | $1.52M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $485K | Sell |
|
|||||
|
2023
Q2 | $1.17M | Sell |
|
|||||
|
2023
Q1 | $1.78M | Buy |
|
|||||
|
2022
Q4 | $844K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.64M | Sell |
|
|||||
|
2021
Q2 | $7.02M | Sell |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|
|||||
|
2020
Q4 | $2.38M | Buy |
|
|||||
|
2020
Q3 | $883K | Sell |
|
|||||
|
2020
Q2 | $2.36M | Sell |
|
|||||
|
2020
Q1 | $3M | Buy |
|
|||||
|
2019
Q4 | $2.29M | Sell |
|
|||||
|
2019
Q3 | $3.47M | Buy |
|
|||||
|
2019
Q2 | $3.14M | Buy |
|
|||||
|
2019
Q1 | $2.61M | Sell |
|
|||||
|
2018
Q4 | $5.51M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $8.09M | Buy |
|
|||||
|
2018
Q1 | $5.84M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $2.29M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $5.34M | Buy |
|